Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Mark A. Mc Niven

Verified by NIH RePORTER profile ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on NIH RePORTER profile ID 1864291. Sources: NIH RePORTER.

Their work

Papers
0
Trials
0
Grants
4
Labs led
1
Collaborators
2
Papers, trials and grants by year

2012: 1 grant · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 grant · 2020: none · 2021: 1 grant · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 grant

Grants 4

  1. Intersection of cytoskeletal regulation with tumor cell metabolism R01CA294653↗
  2. Mayo Clinic Hepatobiliary SPORE Diversity Supplement Dr. Musa Gabere P50CA210964↗
  3. Cytoskeletal Dynamics in Pancreatic Cancer Metastasis R01CA104125↗
  4. Novel therapeutic inhibition of the Rac oncogene in pancreatic cancer R03CA155778↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gina Lynn Razidlo · 2 shared grants, 2019–2026 · strength 1.67
  2. Lewis R Roberts · 1 shared grant, 2021 · strength 0.56

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.